Cancer Biomarkers in Body Fluids

• Muut tekijät: Bianchi, Fabrizio (Toimittaja)
• Aineistotyyppi: Elektroninen Kirjan osa
• Kieli: englanti
• Julkaistu: Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
• Aiheet: Research & information: general; Physics; primary breast cancer; circulating nucleosomes; circulating tumor cells; plasminogen activator inhibitor-1; cytokines; prostate cancer; breast cancer; treatment decisions; exosomes; molecular composition; cancer pathogenesis; diagnostics; therapeutics; leptomeningeal metastasis; cerebrospinal fluid; extracellular vesicle; biomarker; RNA sequencing; small non-coding RNA; microRNA; exo-oncomiRNAS; TWEAK; semen; rheumatoid factor; autoimmunity; autoantibodies; cancer; predictive biomarker; prognostic biomarker; cancer progression; cancer development; immunotherapy; cancer susceptibility; tumor recurrence; tumor load; fecal immunochemical test (FIT); colonoscopy; flexible sigmoidoscopy; liquid biopsy; mRNA; ctDNA; proteins; extracellular vesicles; biomarkers; exosome; lung cancer; miRNA; plasma; serum; volatile organic compounds (VOCs); gas chromatography (GC); mass spectrometry (MS); headspace solid phase microextraction (HS-SPME); breast cancer biomarkers; principal component analysis (PCA); linear discriminant analysis (LDA); principal component regression (PCR); cfDNA; hereditary and familial pancreatic cancer; somatic mutation profiling; potentially druggable genes; uveal melanoma; circulating tumor DNA; next generation sequencing; PKC inhibitor; treatment; response; melanoma; ovarian cancer; lipidomics; lipid; prognosis; ceramide; phospholipid; plasmalogen; patient stratification; outcome; personalized medicine; neuroblastoma; immune monitoring; anti-GD2; IL-2; GM-CSF; ASCT; dinutuximab; anti-PD-1; urothelial cancer; blood biomarkers; NETs; disease modelling; machine learning; metabolic signaling; molecular pathways; plasma metabolites; diagnostic biomarkers; urine; urine liquid biopsy; DNA; sncRNA; bladder cancer; metabolic pathways; metabolism; metabolomics; epigenetics; miRNAs; epigenetic biomarkers; DNA methylation; micro-RNAs; human papillomavirus; oropharyngeal squamous cell carcinoma; treatment de-escalation; E7 oncoprotein; HPV DNA; HPV antibodies; ELISA; cancer biomarkers; diagnosis; early detection; n/a; early diagnosis
• Linkit: DOAB: download the publication; DOAB: description of the publication

Yhteenveto

Liquid biopsy shows promise for cancer screening and diagnostics. This reprint collects recent scientific literature on the identification and application of tumor biomarkers in biological fluids to improve the diagnosis of cancer and the identification of optimal therapeutic strategies.

Ulkoasu

1 electronic resource (490 p.)

ISBN

books978-3-0365-6648-1
9783036566498
9783036566481

Pääsy

Open Access